MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
Open Access
- 23 February 2011
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 18 (8), 2381-2387
- https://doi.org/10.1245/s10434-011-1602-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry.2009
- miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancerCarcinogenesis: Integrative Cancer Research, 2009
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinomaJournal of Hepatology, 2009
- Uncovering Growth-Suppressive MicroRNAs in Lung CancerClinical Cancer Research, 2009
- MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic PancreatitisJama-Journal Of The American Medical Association, 2007
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJama-Journal Of The American Medical Association, 2007
- Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBritish Journal of Cancer, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Pancreatic Cancer Registry in JapanPancreas, 2004
- An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegansScience, 2001